3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoid Interstitial Pneumonia
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Clinical Stage I Gastric Cancer AJCC v8
1
Cholangiocarcinoma
1
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Platinum
3
Cisplatin
3
Cetuximab
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Radiotherapy, Intensity-Modulated
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
ipatasertib
1
durvalumab
1
cabozantinib
1
atezolizumab
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Nivolumab
1
Docetaxel
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
dehydroftorafur
×
30 days
×
Clear all
No trials found.